Equities

SI-BONE Inc

SI-BONE Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)12.64
  • Today's Change0.35 / 2.85%
  • Shares traded133.88k
  • 1 Year change-29.50%
  • Beta1.1917
Data delayed at least 15 minutes, as of Nov 22 2024 19:33 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

  • Revenue in USD (TTM)157.04m
  • Net income in USD-37.40m
  • Incorporated2008
  • Employees344.00
  • Location
    SI-BONE Inc471 El Camino Real, Suite 101SANTA CLARA 95050United StatesUSA
  • Phone+1 (408) 207-0700
  • Fax+1 (408) 557-8312
  • Websitehttps://si-bone.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nano-X Imaging Ltd10.13m-57.47m360.34m164.00--2.06--35.58-0.9974-0.99740.17552.990.0482--6.8961,756.10-27.33-30.98-29.96-35.10-81.80---567.41-1,527.245.09--0.0181--15.47--46.33--114.35--
MaxCyte Inc45.60m-35.74m363.91m143.00--1.70--7.98-0.3420-0.34200.43682.030.1770.55767.17318,878.30-13.87-13.18-14.86-14.3385.9888.79-78.37-62.969.22--0.00---6.7219.89-60.89--39.13--
ZimVie Inc451.30m-47.73m379.21m2.60k--0.9321--0.8403-1.77-13.1616.6014.740.3941.144.04173,575.00-4.17---4.81--63.1865.51-10.58-8.731.38-0.62640.3514---1.26-16.08-19.50---23.70--
Tactile Systems Technology Inc285.05m15.45m382.51m992.0024.791.8417.271.340.6430.64311.918.660.98126.206.80287,349.805.320.90156.201.0951.4449.105.420.83093.80--0.11460.0011.2013.81259.6033.91-23.62--
Alpha Teknova Inc36.35m-31.68m388.05m210.00--4.45--10.68-0.7366-0.73660.8341.640.27703.127.44173,081.00-24.14---25.92--17.71---87.17--3.94-75.860.133---11.43--22.52------
Quanterix Corp129.33m-39.71m449.80m441.00--1.34--3.48-1.04-1.043.408.770.30782.374.60293,265.30-9.45-15.96-10.30-17.6657.4252.79-30.71-53.798.99--0.00--15.9626.6066.56--20.07--
Pacific Biosciences of California Inc173.15m-394.24m482.38m796.00--1.07--2.79-1.46-1.460.641.650.10341.975.78217,521.40-23.55-16.19-25.40-17.8123.8137.35-227.69-136.218.64-21.870.6634--56.2920.592.39--36.68--
Semler Scientific Inc58.94m15.91m482.70m92.0032.425.5429.168.192.052.057.5811.990.686817.209.33640,619.6018.5438.8320.3744.4188.0590.2227.0032.583.09--0.00--20.2825.9843.6932.64-0.3821--
Treace Medical Concepts Inc202.86m-61.52m494.64m516.00--4.71--2.44-0.9924-0.99243.271.680.89511.088.25393,141.50-27.15---32.22--80.61---30.33--2.98--0.3366--31.92---15.68------
SI-Bone Inc157.04m-37.40m515.42m344.00--3.11--3.28-0.9108-0.91083.823.950.68591.467.00456,497.10-16.34-27.88-18.08-30.9477.7085.03-23.82-51.097.22--0.1799--30.5220.1929.25--52.62--
Mesa Laboratories Inc228.38m-245.65m547.81m736.00--3.39--2.40-45.57-45.5742.1329.790.41862.745.96310,298.90-45.02-9.20-54.70-9.8862.4760.60-107.56-28.330.51061.350.5594---1.3215.95-27,438.28--15.260.00
Surmodics Inc126.08m-11.54m559.12m389.00--4.72--4.43-0.8145-0.81458.908.300.69222.206.03324,108.00-6.34-3.99-7.22-4.6673.8180.25-9.15-6.263.22-3.030.1991---4.914.73-651.43---12.34--
AxoGen Inc180.86m-14.31m576.51m426.00--5.80--3.19-0.3302-0.33024.162.260.93561.657.55424,544.60-7.40-13.92-8.49-15.8476.1379.74-7.91-20.282.47-1.500.3224--14.7413.6324.98--17.70--
Simulations Plus Inc70.01m9.95m602.82m243.0061.383.3038.608.610.48940.48943.459.100.3659--5.55288,119.305.206.105.556.4561.6374.0114.2218.97----0.0045.6417.5215.56-0.07033.0117.070.00
Standard Biotools Inc155.90m-170.60m603.06m534.00--1.23--3.87-0.7091-0.70910.55791.310.30542.486.01291,951.30-24.41-28.17-29.37-33.6048.5751.58-79.91-74.853.41--0.1014--8.57-1.2060.73--50.06--
Orthopediatrics Corp189.67m-28.44m641.00m247.00--1.73--3.38-1.24-1.248.2615.320.41160.45094.71767,906.90-6.17-5.40-6.78-5.9373.6875.09-15.00-15.923.68-29.230.1638--21.6220.91-1,767.25--28.29--
Data as of Nov 22 2024. Currency figures normalised to SI-BONE Inc's reporting currency: US Dollar USD

Institutional shareholders

52.94%Per cent of shares held by top holders
HolderShares% Held
Brown Advisory LLCas of 30 Sep 20244.00m9.60%
BlackRock Fund Advisorsas of 30 Sep 20243.26m7.82%
Champlain Investment Partners LLCas of 30 Sep 20242.80m6.72%
The Vanguard Group, Inc.as of 30 Sep 20242.32m5.57%
American Century Investment Management, Inc.as of 30 Sep 20242.14m5.14%
Granahan Investment Management, LLCas of 30 Sep 20241.66m3.97%
Silvercrest Asset Management Group LLCas of 30 Sep 20241.60m3.84%
First Light Asset Management LLCas of 30 Sep 20241.53m3.66%
Bellevue Asset Management AGas of 30 Sep 20241.44m3.46%
Paradigm Capital Management, Inc.as of 30 Sep 20241.32m3.16%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.